Sanford, North Carolina

Sanford Heisler Sharp Announces Approval of $7.75 Million Settlement in Western Digital Gender Discrimination Class and Collective Action

Retrieved on: 
Friday, January 8, 2021

Under the Settlement, over $5 million will be distributed directly to class members according to a settlement formula.

Key Points: 
  • Under the Settlement, over $5 million will be distributed directly to class members according to a settlement formula.
  • Western Digital is a computer data storage company and one of the largest hard disk manufacturers in the world.
  • Danielle Fuschetti, of Sanford Heisler Sharp, LLP also class counsel, added, the Settlement also could not have been achieved without Western Digitals solutions-oriented approach.
  • Sanford Heisler Sharp, class counsel in this case, regularly represents individuals and classes of employees in suits against technology companies.

SECU Foundation Provides New Pilot to Benefit Public Charities in Rural North Carolina

Retrieved on: 
Tuesday, January 5, 2021

Raleigh, N.C., Jan. 05, 2021 (GLOBE NEWSWIRE) -- To expand its reach in rural North Carolina counties, SECU Foundation has announced a new capacity building pilot program to support public charities in the Northwest, Northeast, and Sandhills regions of the state.

Key Points: 
  • Raleigh, N.C., Jan. 05, 2021 (GLOBE NEWSWIRE) -- To expand its reach in rural North Carolina counties, SECU Foundation has announced a new capacity building pilot program to support public charities in the Northwest, Northeast, and Sandhills regions of the state.
  • Expanding the reach of our Foundation throughout North Carolina is a top priority for us, said Jo Anne Sanford, SECU Foundation Board Chair.
  • East Carolina University is pleased to join with SECU Foundation in the Rural Opportunity Grant program.
  • Since 2004, SECU Foundation has made a collective financial commitment of over $200 million for initiatives to benefit North Carolinians statewide.

Woodbridge International Closes Sale of JMC Tool & Machine Co. to B-Square Precision, LLC

Retrieved on: 
Thursday, October 17, 2019

NEW HAVEN, Conn., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Woodbridge International, a global mergers and acquisitions firm, is pleased to announce the acquisition of its client, JMC Tool & Machine Co. by B-Square Precision.

Key Points: 
  • NEW HAVEN, Conn., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Woodbridge International, a global mergers and acquisitions firm, is pleased to announce the acquisition of its client, JMC Tool & Machine Co. by B-Square Precision.
  • JMC Tool & Machine, headquartered in Sanford, North Carolina, produces precision components and assemblies for a variety of end-products including medical equipment and diagnostic services, and filtration and fire suppression systems for industries including aerospace, firearm components, fiber optic tools and more.
  • The founders of B-Square are Mark Beck and Tony Butler who are both based in North Carolina.
  • Woodbridge Internationals ground-breaking approach to marketing a company globally has transformed the way the sell-side M&A industry does business.

Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina

Retrieved on: 
Wednesday, August 21, 2019

Pfizer announced today an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina.

Key Points: 
  • Pfizer announced today an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina.
  • This facility is anticipated to support Pfizers continuing investment in gene therapy research and development, similar to Pfizers Chapel Hill and Kit Creek, North Carolina research and development sites.
  • This facility would expand the companys presence in North Carolina, where there are currently more than 3,600 Pfizer colleagues, including 650 in Sanford.
  • Pfizer is expanding its end-to-end capabilities in gene therapy in North Carolina by investing in facilities focused on all stages of research, development, and manufacturing.